TLPH insider buying and SEC filings, explained
Talphera, Inc. · CIK 1427925
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$304K
Insiders who bought
4
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Mar 13, 2026 | Purchase (code P) | Vincent J. Angotti (CEO and Director) bought 213,310 shares at $0.5900 ($126K), reported as a purchase (code P). Holdings up 36% to 800,705 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 25, 2026 |
| Feb 12, 2026 | Purchase (code P) | Shakil Aslam (Chief Medical Officer) bought 35,000 shares at $0.8100 ($28K), reported as a purchase (code P). Holdings up 73% to 83,178 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 20, 2026 |
| Feb 12, 2026 | Purchase (code P) | Vincent J. Angotti (CEO and Director) bought 105,364 shares at $0.8100 ($85K), reported as a purchase (code P). Holdings up 22% to 586,954 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 20, 2026 |
| Feb 12, 2026 | Purchase (code P) | Raffi Asadorian (CFO) bought 45,000 shares at $0.8100 ($36K), reported as a purchase (code P). Holdings up 97% to 91,256 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 20, 2026 |
| Feb 12, 2026 | Purchase (code P) | Badri N Dasu (Chief Engineering Officer) bought 35,000 shares at $0.8100 ($28K), reported as a purchase (code P). Holdings up 85% to 76,230 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 20, 2026 |
17 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
4 insiders bought in 30 days
$178K in purchases since Feb 12, 2026 · Purchases traded Feb 12, 2026 to Feb 12, 2026 · Closed
| Insider | Value | Traded | Source |
|---|---|---|---|
| Badri N Dasu (Chief Engineering Officer) | $28K | Feb 12, 2026 | SEC filing |
| Raffi Asadorian (CFO) | $36K | Feb 12, 2026 | SEC filing |
| Vincent J. Angotti (CEO) | $85K | Feb 12, 2026 | SEC filing |
| Shakil Aslam (Chief Medical Officer) | $28K | Feb 12, 2026 | SEC filing |
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow TLPH in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.